The UK government on Wednesday announced the formal launch of the world's first nationwide artificial intelligence cancer screening programme, deploying AI-powered diagnostic tools across 200 NHS hospitals in England. Health Secretary Wes Streeting confirmed the rollout at a press conference in London, calling it 'the most significant leap in cancer detection since the introduction of mammography.'

The programme, developed in partnership with Google DeepMind and the NHS AI Lab, uses machine learning algorithms trained on over 12 million anonymised scans to identify early-stage lung and breast cancers that human radiologists frequently miss. Clinical trials conducted at Addenbrooke's Hospital in Cambridge and The Christie in Manchester over the past 18 months demonstrated a 23% improvement in early-stage detection rates, with false positive rates reduced by nearly a third.

Under the new programme, patients attending routine breast screening appointments and those referred for low-dose CT lung scans will have their images analysed simultaneously by AI systems and human radiologists. The AI flags suspicious areas for specialist review, but final diagnostic decisions remain with clinicians. The government has committed £340 million over three years to fund the infrastructure, training, and ongoing evaluation.

Cancer Research UK welcomed the announcement but urged caution. Dr. Iain Foulkes, the charity's executive director of research and innovation, said the technology 'holds genuine promise but must be rigorously monitored in real-world settings to ensure it benefits all patient groups equally, including those from underserved communities.' He noted that AI systems can sometimes perform less accurately on scans from patients with diverse body types or those with pre-existing lung conditions.

The initiative comes as the UK faces a persistent cancer diagnosis backlog, with waiting times for treatment still above pre-pandemic levels in several regions. Prime Minister Keir Starmer, who has made NHS reform a centrepiece of his domestic agenda, said the programme was 'proof that Britain can lead the world in putting cutting-edge technology at the service of public health.' Several countries, including Japan, Australia, and the Netherlands, are reportedly in discussions with NHS England about replicating the model.